Evidence map›Paper›PMID 40859009›Full record

ArticleScientific reports2025

Predicting regional and temporal incidence of RSV and influenza hospitalizations in a birth cohort of young Australian children.

Belaynew Taye, Avram Levy, Mohinder Sarna, Cara Minney-Smith, Robert Menzies, Huong Le, Peter Richmond, Christopher C Blyth, Hannah C Moore

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Belaynew TayeWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, University of Western Australia, Nedlands, Perth, WA, 6009, Australia. Belaynew.taye@thekids.org.au.
Avram LevyPathogen Genomics and Surveillance Unit, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Perth, Australia.
Mohinder SarnaWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, University of Western Australia, Nedlands, Perth, WA, 6009, Australia.
Cara Minney-SmithPathogen Genomics and Surveillance Unit, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Perth, Australia.
Robert MenziesSanofi Vaccines, Australia and New Zealand, Macquarie Park, Sydney, NSW, Australia.
Huong LeWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, University of Western Australia, Nedlands, Perth, WA, 6009, Australia.
Peter RichmondWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, University of Western Australia, Nedlands, Perth, WA, 6009, Australia.
Christopher C BlythWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, University of Western Australia, Nedlands, Perth, WA, 6009, Australia.
Hannah C MooreWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, University of Western Australia, Nedlands, Perth, WA, 6009, Australia.

Funding

Sanofi Australia FLU00200
6 · The paper itself

Abstract

Western Australia (WA) experiences multiple climatic zones, influencing the epidemiology of respiratory viruses. We aimed to estimate the true incidence of respiratory syncytial virus (RSV) and influenza hospitalizations across these different climatic regions using predictive modelling. We conducted a population-based cohort study using linked perinatal, hospitalization and microbiological data of children aged < 5 years, born in WA between 1 January 2010 and 31 December 2021. We used multivariable logistic regression to develop and validate predictive models for RSV and influenza hospitalizations in three climatic regions: southern temperate, northern tropical, and central desert. We compared laboratory-confirmed hospitalization rates with model-predicted rates and determined under-ascertainment fractions. Our cohort comprised 466,037 hospital admissions (257,960 children), with 33,106 tested for RSV (23.4% positive) and 33,511 for influenza (3.6% positive). True hospitalization rates for RSV and influenza were highest in the central desert and northern tropical regions. Among infants, RSV rates were 36.71 versus 20.00 per 1,000 child-years, and influenza rates were 444.59 versus 144.40 per 100,000 child-years in central desert compared to southern temperate areas. Routine laboratory testing significantly underestimated RSV (by 45-69%) and influenza (by 34-52%) hospitalizations. Unlike the southern and desert regions, the northern tropics lacked clear seasonal patterns. The study highlights high under-ascertainment of RSV and influenza hospitalizations from routine viral testing. The findings suggest immunization programs should consider viral circulation timing in different climatic regions. Prediction models demonstrated reliability in estimating RSV and influenza burden across varying climates, supporting localized decision-making beyond Australia.

Indexed as

HospitalizationInfluenza, HumanOrthomyxoviridaeRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsBirth CohortChild, PreschoolDecision MakingFemaleHumansIncidenceInfantInfant, NewbornLongitudinal StudiesMaleMultivariate AnalysisBirth cohortInfluenza virusPredictive modellingRespiratory virusesRSVUnder-ascertainment

Identifiers

PMID40859009
PMCPMC12381019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.